Cancer ‘wonder drug’ launched in Britain
A pill that can help prostate cancer patients live about five months longer was launched in Britain Wednesday
News Section | Prostate Cancer
New treatment options underway for advanced prostate cancer
Researchers at Lund University are developing new methods for treating advanced prostate cancer by
New treatment option for advanced prostate cancer
Prostate cancer that has become resistant to hormone treatment and that does not respond to radiation or
New ‘biomarker’ blood test could improve prostate cancer detection
A new DNA-based “biomarker” blood test that complements the currently offered prostate-specific antigen (PSA) test
Now, a simple urine test may predict prostate cancer risk
A urine test could soon help doctors detect prostate cancer early and better evaluate a patient”s treatment options, according to a new study involving an Indian-origin scientist
‘Puppet-master’ genes behind prostate cancer spread identified
Scientists have found a series of ‘puppet master’ genes that control the growth and spread of prostate cancer – a discovery that offers clues to new target treatments to help slow down
Hormones spurring growth of advanced prostate cancer identified
Scientists have discovered that a different hormonal pathway drives advanced prostate cancer than was previously thought, paving the way for developing potential drug targets against the disease
7 DNA regions that influence prostate cancer risk discovered
It is well known that men with relatives who have been diagnosed with prostate cancer have an elevated risk of developing this type of cancer
Men who smoke increase risk of prostate cancer recurrence, death
A study has suggested that men with prostate cancer who smoke increase their risk of prostate cancer recurrence and of dying from the disease
Half of prostate cancers could be treated with new type of cancer drugs
A new study involving an Indian-origin researcher has suggested that about half of prostate cancer patients could potentially benefit from a new class of cancer-fighting drugs. The drugs, called PARP inhibitors, are currently being tested in breast cancer patients with mutations in the BRCA1 and BRCA2 genes, which are found in up to 10 percent [...]